Judith Inumerable

Judith Inumerable is a highly experienced clinical scientist with a robust background in oncology and hematology, currently working at Syndax Pharmaceuticals as a Clinical Scientist focused on the Revumenib program. Prior to this, Judith held prominent roles in various prestigious organizations, including Senior Director at Cullinan Oncology and Director at Genmab, leading significant clinical research initiatives in areas such as AML/MDS, B-NHL, and multiple myeloma. Judith has a comprehensive educational background with advanced degrees in biotechnology from esteemed institutions including The Johns Hopkins University and Harvard University, complemented by an MBA certificate in Pharmaceutical Science from Fairleigh Dickinson University.